microdose glp 1 reviews Why GLP-1 Microdosing? A Closer Look at Reported Benefits Microdosing GLP-1s: A Doctor's Guide

In older patients, retatrutide weight loss may result in more skin laxity

The results, which appear March 18 in BMJ Medicine, show that the consequences of stopping GLP-1 drugs go beyond weight regain, extending to increased cardiovascular risk, and underscore the importance of continuous treatment for sustained heart protection

The body becomes more efficient at storing energy to support fetal development and prepare for breastfeeding

As Insl5 is not expressed in pancreatic islets (164, 168), any direct effects of endogenous INSL-5 on islets would appear to occur in an endocrine fashion

Retatrutide's glucagon receptor activity increases energy expenditure and metabolic rate

This story is from The Pulse, a weekly health and science podcast